Cell typing of biological heart valves prosthesis explanated due to the development of calcium-associated dysfunctions

Purpose. To perform immunohistochemical typing of cells obtained from calcinated biological heart valve prosthesis removed during reoperations.

Materials and methods. We investigated 19 models (“KemCor” and “PeriCor”) of biological heart valve prosthesis produced by NeoCor Company (Kemerovo, Russia) and removed from the mitral position due to the development of primary tissue inconsistency with calcification. The following markers were used for immunohistochemical cells typing in the analyzed samples: CD3 (T-lymphocytes), CD20 (B-lymphocytes), CD34 and VEGFR2 (endotheliocytes), CD68 (monocytes/macrophages), vimentin (fibroblasts), and α-smooth muscle actin (smooth myocytes).

Results. Uneven distribution and wide variety of intercellular interactions, as well as contacts with matrix components and mineral deposits, were observed. In case of endotheliocytes (CD34 and VEGFR2 positive cells) two types of localization were described. In the first variant, they formed a monolayer on the surface of biological prosthesis flaps; in the second variant, they were a part of capillary-like structures in the surface of the xenomaterial. CD68 positive cells were found both in a surface and in deep layers of the samples. Near such cells fragmentation and stratification of collagen fibers with the formation of fine-fibrous cellular networks were detected. Vimentin-positive cells (fibroblasts) were located in groups or singly in the sites of destruction of the connective tissue and took part in the formation of a new matrix. The density of α-smooth muscle actin-positive cells, morphologically identical to myocytes, was high in the surface of biological prosthesis flaps and low in the deeper layers. CD3 and CD20 positive cells related to T- and B-lymphocytes, respectively, were represented by the single cells in most of analyzed samples.

Conclusions. Maintaining of the structural and functional integrity of biological heart valve prosthesis, in addition to the characteristics of the implantable devices, defines a complex of recipient factors, including not only mechanical damage during operation, but also various immune and cellular mechanisms.

biological heart valve prosthesis, calcification, cells typing

1. Kaneko T., Aranki S., Javed Q., McGurk S., Shekar P., Davidson M, Cohn L. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J. Thorac. Cardiovasc. Surg. 2014; 147 (1): 117–126. DOI: 10.1016/j.jtcvs.2013.08.028.

2. Barbarash L.S., Zhuravleva I.Yu. Bioprosthetic heart valve evolution: two decades of advances and challenges. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy – Complex Problems of Cardiovascular Diseases. 2012; 1: 4–11 (in Russ.). DOI:10.17802/2306-1278-2012-1-4-11.

3. Ovcharenko E.A., Klyshnikov K.Yu., Savrasov G.V., Glushkova T.V., Barbarash L.S. Investigation of the hydrodynamic performance of the minimally invasive aortic valve prosthesis. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy – Complex Problems of Cardiovascular Diseases. 2016; 5 (2): 39–45 (in Russ.). DOI: http://dx.doi.org/10.17802/2306-1278-2016-2-39-45.

4. Barbarash O.L., Rutkovskaya N.V., Hryachkova O.N., Gruzdeva O., Uchasova E., Ponasenko A., Kondyukova N., Odarenko Y., Barbarash L. Impact of recipient-related factors on structural dysfunction rates of xenoaortic bioprothetic heart valve. Pat. Pref. Adher. 2015; 9: 389–399. DOI: https://doi.org/10.2147/PPA.S76001

5. Mukhamadiyarov R.A., Rutkovskaya N.V., Mil’to I.V., Kudryavtseva Yu.А., Barbarash L.S. Pathogenetic parallels between the development of calcification of native aortic valves and xenogenic bioprostheses of heart valves. Geny i kletki – Genes and Cells. 2016; 11(3): 83–91 (in Russ.)].

6. Mukhamadiyarov R.A., Rutkovskaya N.V., Sidorova O.D., Barbarash L.S. Cellular composition of calcified bioprosthetic heart valves. Vestnik RAMN – Annals of the Russian Academy of Medical Sciences. 2015; 70 (6): 662–668 (in Russ.)].

7. Ruiz J.L., Hutcheson J.D., Aikawa E. Cardiovascular calcification: Current controversies and novel concepts. Cardiovasc. Pathol. 2015; 24 (4): 207–212. DOI: 10.1016/j.carpath.2015.03.002.

8. Evrard S., Delanaye P., Kamel S., Cristol J.P., Cavalier E., Urena-Torres P. et al. Vascular calcification: from pathophysiology to biomarkers. Clinica Chimica Acta. 2015; 438: 401–414. DOI: 10.1016/j.cca.2014.08.034.

9. Pal S.N., Golledge J. Osteo-progenitors in vascular calcification: a circulating cell theory. J. Atheroscler. Thromb. 2011; 18: 551–559. DOI: http://doi.org/10.5551/jat.8656.

10. Qin X., Corriere M.A., Matrisian L.M., Guzman R.J. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler. Thromb. Vasc. Biol. 2006; 26 (7): 1510–1516. DOI: 10.1161/01.ATV.0000225807.76419.a7.

11. Sophie E.P., Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 2011; 108: 1381–1391. DOI: 10.1161/CIRCRESAHA.110.234146.

12. Kim J.J., Hou L., Huang N.F. Vascularization of three-dimensional engineered tissues for regenerative nedicine applications. Acta Biomaterialia. 2016; 41: 17–26. http://dx.doi.org/10.1016/j.actbio.2016.06.001.

13. Jansson K., Bengtsson L., Swedenborg J., Haegerstrand. In vitro endothelialization of bioprosthetic a.heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow. The Journal of Thoracic and Cardiovascular Surgery. 2001; 121 (1): 108–115. http://dx.doi.org/10.1067/mtc.2001.110251.

14. Nina V.J.S., Pomerantzeff P.M.A., Casagrande I.S.J., Chung D. In vivo endothelialization of cardiac bioprostheses: conventional versus non-aldehyde preservation. Braz. J. Cardiovasc. Surg. 2004; 19 (2): 144–151. http:// dx.doi.org/10.1590/S0102-76382004000200008.

15. Hutcheson J.D., Goettsch C., Rogers M.A., Aikawa E. Revisiting cardiovascular calcification: A multifaceted disease requiring a multidisciplinary approach. Semin. Cell. Dev. Biol. 2015: 46: 68–77. http://dx.doi.org/10.1016/j.semcdb.2015.09.004